Literature DB >> 28687693

Adrenal crisis in metastatic breast cancer.

Bernhard Doleschal, Andreas Petzer1, Karl J Aichberger.   

Abstract

A female patient with oestrogen receptor-positive and human epidermal growth factor receptor 2 (HER2)-positive invasive lobular breast cancer presented with progressive disease on CT scan. Some days after initiation of antineoplastic chemotherapy and anti-HER2 targeted antibody therapy, the patient presented with profuse diarrhoea, neutropaenia, nausea and weakness. Although Clostridium difficile was rapidly tackled as a causative agent of gastrointestinal complaints, clinical situation did not markedly improve despite proper antimicrobial treatment. The patient reported profound lack of energy, while nausea, vomiting and loose stools still persisted. Additionally slightly exaggerated pigmentation of nonsunexposed skin and mucosal areas led us to the assumption of proopiomelanocortin-derived peptide hypersecretion. The combination of highly elevated adrenocorticotropic hormone and low basal cortisol levels taken from a morning blood sample established the diagnosis of adrenal insufficiency due to metastatic burden, leading to a near Addison crisis by gastrointestinal complications of chemo-immune therapy. Administration of hydrocortisone immediately relieved general symptoms . © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  adrenal disorders; breast cancer; chemotheraphy

Mesh:

Substances:

Year:  2017        PMID: 28687693      PMCID: PMC5535009          DOI: 10.1136/bcr-2017-220284

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  Rapidly reversible ECG abnormalities in chronic secondary adrenal insufficiency.

Authors:  P Maffei; S Cajola; C Abrahamsohn; C Martini
Journal:  Int J Cardiol       Date:  2002-12       Impact factor: 4.164

2.  Inverted T waves in patient with Addisonian crisis.

Authors:  Firat Ozcan; Ihsan Ustun; Dilek Berker; Yusuf Aydin; Tuncay Delibasi; Serdar Guler
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

3.  Neutropenic colitis during standard dose combination chemotherapy with nedaplatin and irinotecan for testicular cancer.

Authors:  Ei-Ichiro Takaoka; Koji Kawai; Satoshi Ando; Toru Shimazui; Hideyuki Akaza
Journal:  Jpn J Clin Oncol       Date:  2006-01-25       Impact factor: 3.019

Review 4.  Predisposing factors for adrenal insufficiency.

Authors:  Stefan R Bornstein
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

Review 5.  Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital.

Authors:  K-Y Lam; C-Y Lo
Journal:  Clin Endocrinol (Oxf)       Date:  2002-01       Impact factor: 3.478

6.  Adrenocortical function in patients with macrometastases of the adrenal gland.

Authors:  A Lutz; M Stojkovic; M Schmidt; W Arlt; B Allolio; M Reincke
Journal:  Eur J Endocrinol       Date:  2000-07       Impact factor: 6.664

Review 7.  Adrenal incidentaloma.

Authors:  L M Brunt; J F Moley
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

8.  Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer.

Authors:  N K Ibrahim; A A Sahin; R A Dubrow; P M Lynch; L Boehnke-Michaud; V Valero; A U Buzdar; G N Hortobagyi
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

9.  Adrenal insufficiency caused by bilateral adrenal metastases -- a rare treatable cause for recurrent nausea and vomiting in metastatic breast cancer.

Authors:  Claudia Bausewein; Robert Kühnbach; Birgit Haberland
Journal:  Onkologie       Date:  2006-05-03

10.  Cytomegalovirus colitis after systemic chemotherapy in a patient with recurrent colon cancer: a case report.

Authors:  Fuminori Teraishi; Hiroshi Shimamura; Takeo Suzuki; Masako Nakamoto; Akira Chikuba; Masashi Nezu; Shun Kohsaka; Takao Takiue; Hiroshi Chikuba
Journal:  J Med Case Rep       Date:  2008-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.